CRISPR is like software programming for DNA, and U.K.-based researchers just demonstrated how to use it to stop tomatoes from converting their natural vitamin D into cholesterol. Jeff sees this as a huge development…
With the potential for more aggressive interest-rate hikes and rising inflation, it makes sense to approach this market with caution. So where should investors turn next? Jeff Brown has a unique strategy to propose – one that he has never shared before – that he calls “mandated money.”
A recent Bleeding Edge topic, DeSoc, would provide a way to document and validate our key credentials. But our readers have varied opinions – and concerns – about this concept…
Volatility is scaring investors away from potentially groundbreaking investments, so where should we turn next? Jeff Brown has been following a singular trend that’s allowing investors to invest in the most exciting private companies – before they go public… what he likes to call “Mandated Money” deals.
With all of the fear in the market, Jeff has been keeping a close eye on indicators that allow us to step back and have perspective. And one such indicator is the world's largest semiconductor foundry, TSMC…
While the stock market remains volatile, investors are on the hunt for any kind of “safe” investment they can find. That’s why Jeff Brown has been researching one class of unique private deals that allow cautious investors to protect their capital over time…
With the focus on the Fed this week, Jeff takes a look at a policy tool we don’t usually hear about – Yield Curve Control (YCC).